HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick De Baetselier Selected Research

phenylenediamine mustard

4/2004Efficient cancer therapy with a nanobody-based conjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick De Baetselier Research Topics

Disease

37Infections
01/2022 - 04/2003
27Neoplasms (Cancer)
01/2021 - 03/2002
23Inflammation (Inflammations)
01/2022 - 03/2005
13Anemia
01/2020 - 02/2004
9Trypanosomiasis
06/2011 - 02/2004
8African Trypanosomiasis (Nagana)
01/2022 - 02/2004
5Tuberculosis (Tuberculoses)
01/2014 - 03/2005
4Chronic Disease (Chronic Diseases)
01/2015 - 01/2008
4Asthma (Bronchial Asthma)
12/2011 - 01/2005
4Parasitemia
08/2008 - 02/2004
3Neoplasm Metastasis (Metastasis)
01/2014 - 05/2003
3Parasitic Diseases (Parasitic Disease)
08/2010 - 03/2005
3Hypersensitivity (Allergy)
06/2010 - 02/2004
2Hepatitis
01/2017 - 02/2015
2Experimental Arthritis
10/2016 - 05/2013
2Granuloma
07/2015 - 03/2005
2Rheumatoid Arthritis
05/2014 - 05/2013
2Immune Reconstitution Inflammatory Syndrome
01/2014 - 07/2013
2Carcinoma (Carcinomatosis)
07/2010 - 05/2008
2Bites and Stings (Sting)
05/2009 - 08/2006
2Lymphoma (Lymphomas)
05/2008 - 12/2007
2Eosinophilia
07/2006 - 01/2005
1Communicable Diseases (Infectious Diseases)
01/2022
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2018
1Shock
01/2018
1Septic Shock (Toxic Shock Syndrome)
01/2018
1Choline Deficiency
01/2017
1Alcoholic Fatty Liver
01/2017
1Drug-Related Side Effects and Adverse Reactions
01/2017
1Arthritis (Polyarthritis)
10/2016
1Hypoalbuminemia
01/2016
1Hyperbilirubinemia
01/2016
1Hypoxia (Hypoxemia)
01/2014
1Breast Neoplasms (Breast Cancer)
08/2012
1Virus Diseases (Viral Diseases)
01/2012
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2011

Drug/Important Bio-Agent (IBA)

19Single-Domain AntibodiesIBA
01/2018 - 03/2002
17CytokinesIBA
01/2022 - 01/2002
11Interleukin-10 (Interleukin 10)IBA
01/2022 - 02/2004
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009 - 05/2003
7IronIBA
01/2016 - 01/2008
6AntibodiesIBA
01/2017 - 03/2002
5Biomarkers (Surrogate Marker)IBA
01/2017 - 05/2003
5LigandsIBA
12/2011 - 07/2006
5AntigensIBA
07/2010 - 03/2002
5Interferon-gamma (Interferon, gamma)IBA
09/2008 - 02/2004
4Membrane Glycoproteins (Membrane Glycoprotein)IBA
11/2014 - 05/2006
4ArginaseIBA
10/2013 - 05/2003
4Interleukin-6 (Interleukin 6)IBA
03/2008 - 03/2005
4Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2007 - 05/2003
4Interleukin-12 (IL 12)IBA
09/2007 - 01/2005
3Macrophage Migration-Inhibitory FactorsIBA
01/2022 - 01/2018
3Mannose ReceptorIBA
08/2015 - 08/2012
3DNA (Deoxyribonucleic Acid)IBA
11/2014 - 07/2007
3Messenger RNA (mRNA)IBA
01/2014 - 11/2006
3Proteins (Proteins, Gene)FDA Link
07/2010 - 04/2003
3Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
05/2010 - 09/2007
3ErbB Receptors (EGF Receptor)IBA
11/2009 - 05/2008
3AllergensIBA
05/2009 - 01/2005
3Immunoglobulin M (IgM)IBA
08/2008 - 06/2006
3Secretory Leukocyte Peptidase InhibitorIBA
12/2006 - 05/2003
2Galectin 3 (LGALS3)IBA
01/2018 - 09/2010
2Virulence Factors (Pathogenicity Factors)IBA
01/2017 - 01/2017
2C-Type Lectins (C-Type Lectin)IBA
01/2017 - 03/2005
2Concanavalin AIBA
01/2017 - 02/2015
2Macrophage Colony-Stimulating FactorIBA
01/2016 - 01/2014
2Monoclonal AntibodiesIBA
01/2016 - 12/2007
2Cadherins (E-Cadherin)IBA
07/2015 - 11/2009
2Carcinoembryonic AntigenIBA
07/2010 - 04/2004
2EnzymesIBA
07/2010 - 04/2004
2Complementary DNA (cDNA)IBA
05/2009 - 12/2004
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2009 - 09/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2008 - 05/2005
2Lipoproteins (Lipoprotein)IBA
07/2007 - 01/2005
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
05/2007 - 02/2004
2EpitopesIBA
05/2006 - 03/2002
2LectinsIBA
11/2003 - 01/2002
1Interleukin-10 ReceptorsIBA
01/2022
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1GlucocorticoidsIBA
01/2018
1Methionine (L-Methionine)FDA Link
01/2017
1Biological ProductsIBA
01/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2016
1Complement Receptors (Complement Receptor)IBA
10/2016
1Heme (Haem)IBA
01/2016
1BilirubinIBA
01/2016
1CC ChemokinesIBA
08/2015
1KinesinsIBA
11/2014
1Pharmaceutical PreparationsIBA
05/2014
1Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA
01/2014
1Oxygen (Dioxygen)IBA
01/2014
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
01/2014
1Complement System Proteins (Complement)IBA
07/2013
1SuspensionsIBA
08/2012
1Nicotinamide PhosphoribosyltransferaseIBA
01/2012

Therapy/Procedure

15Therapeutics
01/2022 - 04/2004
2Hemodilution
01/2018 - 01/2016
2Investigational Therapies (Experimental Therapy)
11/2006 - 05/2006
1Immunotherapy
12/2015
1Intravenous Injections
08/2012